151 related articles for article (PubMed ID: 38050862)
1. Computationally Designed Molecules Modulate ALS-Related Amyloidogenic TDP-43
Liu X; Duan S; Jin Y; Walker E; Tsao M; Jang JH; Chen Z; Singh AK; Cantrell KL; Ingolfsson HI; Buratto SK; Bowers MT
ACS Chem Neurosci; 2023 Dec; 14(24):4395-4408. PubMed ID: 38050862
[TBL] [Abstract][Full Text] [Related]
2. Modulating ALS-Related Amyloidogenic TDP-43
Laos V; Bishop D; Lang CA; Marsh NM; Cantrell KL; Buratto SK; Singh AK; Bowers MT
Biochemistry; 2020 Feb; 59(4):499-508. PubMed ID: 31846303
[TBL] [Abstract][Full Text] [Related]
3. Characterizing TDP-43
Laos V; Do TD; Bishop D; Jin Y; Marsh NM; Quon B; Fetters M; Cantrell KL; Buratto SK; Bowers MT
ACS Chem Neurosci; 2019 Sep; 10(9):4112-4123. PubMed ID: 31430111
[TBL] [Abstract][Full Text] [Related]
4. Catalytic Cross Talk between Key Peptide Fragments That Couple Alzheimer's Disease with Amyotrophic Lateral Sclerosis.
Laos V; Bishop D; Ganguly P; Schonfeld G; Trapp E; Cantrell KL; Buratto SK; Shea JE; Bowers MT
J Am Chem Soc; 2021 Mar; 143(9):3494-3502. PubMed ID: 33621087
[TBL] [Abstract][Full Text] [Related]
5. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
[TBL] [Abstract][Full Text] [Related]
6. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Takeda T
Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 skeins show properties of amyloid in a subset of ALS cases.
Robinson JL; Geser F; Stieber A; Umoh M; Kwong LK; Van Deerlin VM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2013 Jan; 125(1):121-31. PubMed ID: 23124365
[TBL] [Abstract][Full Text] [Related]
8. ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.
Lim L; Wei Y; Lu Y; Song J
PLoS Biol; 2016 Jan; 14(1):e1002338. PubMed ID: 26735904
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the effect of ALS mutation S375G on the conformational properties and aggregation dynamics of TDP-43
Xu Z; Zhang J; Tang J; Gong Y; Zou Y; Zhang Q
Biophys Chem; 2024 Jul; 310():107230. PubMed ID: 38615537
[TBL] [Abstract][Full Text] [Related]
10. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD.
Tamaki Y; Urushitani M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293362
[TBL] [Abstract][Full Text] [Related]
11. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
[TBL] [Abstract][Full Text] [Related]
12. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
13. Cryo-EM observation of the amyloid key structure of polymorphic TDP-43 amyloid fibrils.
Sharma K; Stockert F; Shenoy J; Berbon M; Abdul-Shukkoor MB; Habenstein B; Loquet A; Schmidt M; Fändrich M
Nat Commun; 2024 Jan; 15(1):486. PubMed ID: 38212334
[TBL] [Abstract][Full Text] [Related]
14. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
[TBL] [Abstract][Full Text] [Related]
15. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
16. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
17. Structure of pathological TDP-43 filaments from ALS with FTLD.
Arseni D; Hasegawa M; Murzin AG; Kametani F; Arai M; Yoshida M; Ryskeldi-Falcon B
Nature; 2022 Jan; 601(7891):139-143. PubMed ID: 34880495
[TBL] [Abstract][Full Text] [Related]
18. TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Baloh RH
FEBS J; 2011 Oct; 278(19):3539-49. PubMed ID: 21777387
[TBL] [Abstract][Full Text] [Related]
19. Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Riku Y
Neuropathology; 2020 Oct; 40(5):426-435. PubMed ID: 32157757
[TBL] [Abstract][Full Text] [Related]
20. TDP-43 Pathology in Alzheimer's Disease.
Meneses A; Koga S; O'Leary J; Dickson DW; Bu G; Zhao N
Mol Neurodegener; 2021 Dec; 16(1):84. PubMed ID: 34930382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
